Sitagliptin and GTS-21 together may improve blood sugar control and kidney damage by reducing cell death in diabetic mice

GTS-21 may enhance glycemic control and reduce diabetic nephropathy when combined with sitagliptin in Leprdb/db mice.

• Activation of the α7 nicotinic acetylcholine receptor is linked to the cholinergic anti-inflammatory pathway.
• The study explores the potential benefits of combining GTS-21 with sitagliptin, a medication that increases levels of GLP-1.
• GTS-21 could provide additional benefits beyond those of sitagliptin alone, particularly regarding glycemic control.
• The focus includes examining how this combination may affect mechanisms that prevent cell death.

Simplified